Landmark study opens door to new cancer, aging treatments

Courtesy EurekAlert! - Cancer  Sat, 08/30/2008 - 23:00

(The Wistar Institute) Researchers at the Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers.

The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.

The study will be published online in Nature on Aug. 31.


 

Reply

The content of this field is kept private and will not be shown publicly.